UUnited Kingdom Read More Rein Therapeutics Expands Phase 2 RENEW Trial into United KingdomJune 11, 2026 Rein Therapeutics 16 patients enrolled to date in trial of LTI-03 in idiopathic pulmonary fibrosis (IPF) First patient…